0001209191-15-016654.txt : 20150220
0001209191-15-016654.hdr.sgml : 20150220
20150220160843
ACCESSION NUMBER: 0001209191-15-016654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150218
FILED AS OF DATE: 20150220
DATE AS OF CHANGE: 20150220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 15635738
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-02-18
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197032
SMITH IAN F
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP & CFO
Common Stock
2015-02-18
4
S
0
5250
112.66
D
129276
D
Common Stock
2015-02-18
4
S
0
5100
113.13
D
124176
D
Common Stock
5306
I
401(k)
Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $112.66 (range $111.99 to $112.98).
Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $113.13 (range $112.99 to $113.39).
Omar White, Attorney-In-Fact
2015-02-20